Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

BACKGROUND: The contraceptive skin patch (CSP) accepted by the U.S. FDA in 2001 includes ethinylestradiol and norelgestromine, whereas the subdermal contraceptive implant (SCI) has etonogestrel and is also approved by the FDA. In Mexico, both are now widely used for contraception but their effects o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hernandez-Juarez, Jesus, Garcia-Latorre, Ethel A, Moreno-Hernandez, Manuel, Moran-Perez, Jose Fernando, Rodriguez-Escobedo, Miguel Angel, Cogque-Hernandez, Gerardo, Julián-Nacer, Rubén, Hernandez-Giron, Xochitl, Palafox-Gomez, Rosalia, Isordia-Salas, Irma, Majluf-Cruz, Abraham
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4044294/
https://ncbi.nlm.nih.gov/pubmed/24767248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4755-11-33
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia